API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.indianpharmapost.com/drug-approval/strides-receives-usfda-approval-for-sevelamer-carbonate-tablets-15631
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215537
https://lupin.com/portfolio/lupin-receives-approval-for-sevelamer-carbonate-tablets/#:~:text=Mumbai%2C%20Baltimore%2C%20January%2025%2C,800%20mg%2C%20of%20Genzyme%20Corporation.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211316
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207759
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201069
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212970
https://www.indiainfoline.com/article/news-top-story/dr-reddy-s-launches-sevelamer-carbonate-in-us-118122700232_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204451
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210464
https://www.ema.europa.eu/documents/product-information/sevelamer-carbonate-zentiva-epar-product-information_en-0.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207288
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203860
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090975
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-gets-usfda-nod-for-generic-version-of-renvela-tablets/articleshow/61260104.cms
https://www.prnewswire.com/news-releases/impax-announces-fda-approval-and-launch-of-generic-renvela-sevelamer-carbonate-tablets-800-mg-300541365.html
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-usfda-nod-for-oral-suspension/articleshow/59158317.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207624
http://www.fiercepharmamarketing.com/story/sanofi-adds-its-sales-heft-relypsas-forthcoming-patiromer-launch/2015-08-14